Aurora Cannabis Positioned Coast to Coast with Provincial Supply Arrangements Appoints Darren Karasiuk as Executive Vice President of Adult Usage, Global
WKN: A1C4WM) today announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia , Alberta , Ontario , Quebec and Nova Scotia , the Company is pleased to advise of arrangements with Yukon , Manitoba , Prince Edward Island and Newfoundland and Labrador . The Aurora and MedReleaf brands are expected to have a strong presence across Canada , positioning the Company well for rapid growth in the upcoming adult use market.
Aurora Cannabis says it currently has no partnership with a beverage company
Aurora Cannabis Inc. said Tuesday, in response to a regulator's request for comment regarding media reports, that it currently had "no agreement, understanding or arrangement" with respect to a partnership with a beverage company. The stock rallied 5.3% in morning trade. On Monday, the stock soared 18% after a report that Coca-Cola Co. had been in talks with the company. Coke had declined to comment, but confirmed it was closely watching the growth of non-psychoactive CBD as an ingredient in beverages. On Tuesday, Aurora said its policy is not to comment on speculative media reports, but the Investment Industry Regulatory Organization of Canada (IIROC) requested a comment. Aurora's U.S.-listed shares have run up 18% over the past three months, while Coke shares have gained 6.1% and the Dow Jones Industrial Average has tacked on 4.6%.
4
ACCESSWIRE•4 hours ago
Cannabis and Biotech Stocks That Could Skyrocket
HENDERSON, NV / ACCESSWIRE / September 18, 2018 / A very interesting biotech firm DCTH (Delcath Systems, Inc.), has an intriguing treatment for liver cancer. The company has initiated a global Phase 3 ...
1
CNW Group•5 hours ago
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Companies
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Companies
1
ACCESSWIRE•5 hours ago
3 Marijuana Stocks Benefiting From Latest Bull Trend
CORAL GABLES, FL / ACCESSWIRE / September 18, 2018 / Cannabis stocks continue to soar as the market prepares for October 17 and the deadline for legal recreational marijuana sales in Canada. This week it was announced that Coca-Cola (KO) could be ready to throw its hat into the ring with a CBD-based beverage. Integrated Cannabis Company is trading 90% higher than it was a month ago today.
1
Enjoy Coke — and the money it might make for marijuana investors
MarketWatch•5 hours ago
Enjoy Coke — and the money it might make for marijuana investors
Cannabis companies are striking deals with large beverage companies, a catalyst for marijuana stocks.
2
InvestorPlace•5 hours ago
3 Reasons Why Coca-Cola Stock Won’t Benefit from a CBD Beverage
As an integral component of Americana, Coca-Cola (NYSE:KO) doesn’t really generate much news. While Coca-Cola stock earns respect for turning around its business and making its products relevant to today’s youth, the soft-drink sector is extremely competitive. Plus, it could spark a new reason to invest in Coca-Cola stock.
3
How Coca-Cola Cannabis Drink Could Fit into Cannabis Market
Market Realist•7 hours ago
How Coca-Cola Cannabis Drink Could Fit into Cannabis Market
Earlier in this series, we discussed a recent development in which Coca-Cola (KO) was reported to be in talks with Aurora Cannabis (ACB) (ACBFF) to develop a cannabis-infused drink (MJ). The planned legalization of recreational cannabis in Canada is presenting a new market for non-cannabis players to explore. Thus, it is no surprise to see that Canopy Growth (CGC) (WEED) and HEXO (HEXO) have both pursued deals with alcoholic beverage companies.
1
Cannabis Stocks Get Another Boost from Coca-Cola Interest
Market Realist•7 hours ago
Cannabis Stocks Get Another Boost from Coca-Cola Interest
On September 17, BNN Bloomberg reported that Aurora Cannabis (ACB) (ACBFF) and Coca-Cola (KO) are in “serious talks” to develop cannabis-infused beverages. Coca-Cola joins alcoholic beverage makers Constellation Brands (STZ) and Molson Coors (TAP), which have already formed partnerships with major Canadian cannabis companies Canopy Growth (WEED) (CGC) and HEXO (HEXO), respectively.
Aurora Cannabis Inc. produces and distributes medical cannabis products in Canada and internationally. It is vertically integrated and horizontally diversified across every principal segment of the value chain, including facility engineering and design, cannabis breeding and genetics research, cannabis and hemp production, derivatives, value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil. It has a strategic agreement with Capcium Inc.; and partnership agreement with Evio Beauty Group Ltd., as well as collaborative agreement with McGill University. Aurora Cannabis Inc. is headquartered in
EDMONTON , Sept. 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company"
(ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia , Alberta , Ontario , Quebec and Nova Scotia , the Company is pleased to advise of arrangements with Yukon , Manitoba , Prince Edward Island and Newfoundland and Labrador . The Aurora and MedReleaf brands are expected to have a strong presence across Canada , positioning the Company well for rapid growth in the upcoming adult use market.
Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)
Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)
Appointment Darren Karasiuk , EVP of Adult Usage, Global
The Company also announces the appointment of Darren Karasiuk as its new Executive Vice President of Adult Usage, Global. Mr. Karasiuk will be responsible for the execution of Aurora's commercial adult use strategy, which includes oversight of adult use retail, marketing, sales, business intelligence and analytics, partnerships and customer service.
Mr. Karasiuk joins Aurora through the acquisition of MedReleaf where he was Senior Vice-President and GM, recreational where he was responsible for MedReleaf's adult use cannabis business which included the development and introduction of the AltaVie and San Rafael '71 brands into the marketplace, as well as the stewardship of the partnership with the Woodstock Cannabis Company.
Mr. Karasiuk has deep experience in highly regulated industries, including private and public healthcare, pharma, tobacco, consumer packaged goods, and energy. Prior to joining MedReleaf, Mr. Karasiuk was Vice-President, Insights and Advisory at Deloitte where he was a leader in the firm's cannabis practice, co-authoring the firm's seminal study, "Recreational Marijuana: Insights and Opportunities." Previously, Mr. Karasiuk was Vice-President, Strategy, Corporate and Public Affairs at Environics Research, where he conducted many of Canada's earliest engagements on the cannabis sector. He has also been the Canadian associate for the Marijuana Policy Group, a leading Denver -based economic and policy consulting firm which helped shape the regulated medical and recreational cannabis markets. Mr. Karasiuk holds an MA from Western University and an MBA from Kellogg-Schulich.
Management Commentary
"We have now secured important supply arrangements from coast to coast, covering approximately 98% of the Canadian population, reflecting the scale and quality of our operations," said Terry Booth , CEO. "We will supply a large number of products to the adult use market, including dried flower, and higher margin form factors, such as capsules, oils, and pre-rolls. We are also exceptionally pleased that Darren has agreed to join our team and take on the leadership of Aurora's adult usage business. His expertise in market development within heavily regulated environments, his track record in bringing adult usage brands to market, and his connections and credibility throughout the industry are invaluable assets for us. We welcome Darren and look forward to working closely with him as Aurora rises to new heights."
Mr. Karasiuk added, "Aurora is an exceptional company, innovating and executing at the most rapid pace in the industry. The strengths of both companies – high-volume, low-cost cultivation capacity, product quality, brands and people - position us well to grow rapidly in these new and exciting markets. I look forward to being part of the team."
Granting of Stock Options and Restricted Share Units to Officers
The Company also announced today that it has granted an aggregate of 205,000 stock options and 55,000 restricted share units to officers of the Company. The stock options are exercisable at a price of $8.54 per share for a period of five years from the date of grant. Both options and RSUs vest annually over 36 months.
About Aurora
Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per year and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland (formerly Pedanios), have achieved this level of certification.
In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TGOD.TO), Radient Technologies Inc. (RTI.V), Hempco Food and Fiber Inc. (HEMP.V), Cann Group Ltd. (CAN.AX), Micron Waste Technologies Inc. (CSE:MWM), Choom Holdings Inc. (CSE:CHOO), Namaste Technologies Inc. (TSXV:N.V), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (CTTH), and Alcanna Inc. (CLIQ.TO).
Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram
Terry Booth , CEO
Aurora Cannabis Inc.
WKN: A1C4WM) today announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia , Alberta , Ontario , Quebec and Nova Scotia , the Company is pleased to advise of arrangements with Yukon , Manitoba , Prince Edward Island and Newfoundland and Labrador . The Aurora and MedReleaf brands are expected to have a strong presence across Canada , positioning the Company well for rapid growth in the upcoming adult use market.
Aurora Cannabis says it currently has no partnership with a beverage company
Aurora Cannabis Inc. said Tuesday, in response to a regulator's request for comment regarding media reports, that it currently had "no agreement, understanding or arrangement" with respect to a partnership with a beverage company. The stock rallied 5.3% in morning trade. On Monday, the stock soared 18% after a report that Coca-Cola Co. had been in talks with the company. Coke had declined to comment, but confirmed it was closely watching the growth of non-psychoactive CBD as an ingredient in beverages. On Tuesday, Aurora said its policy is not to comment on speculative media reports, but the Investment Industry Regulatory Organization of Canada (IIROC) requested a comment. Aurora's U.S.-listed shares have run up 18% over the past three months, while Coke shares have gained 6.1% and the Dow Jones Industrial Average has tacked on 4.6%.
4
ACCESSWIRE•4 hours ago
Cannabis and Biotech Stocks That Could Skyrocket
HENDERSON, NV / ACCESSWIRE / September 18, 2018 / A very interesting biotech firm DCTH (Delcath Systems, Inc.), has an intriguing treatment for liver cancer. The company has initiated a global Phase 3 ...
1
CNW Group•5 hours ago
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Companies
Aurora Cannabis Responds to Media Reports Concerning Rumoured Partnership with Beverage Companies
1
ACCESSWIRE•5 hours ago
3 Marijuana Stocks Benefiting From Latest Bull Trend
CORAL GABLES, FL / ACCESSWIRE / September 18, 2018 / Cannabis stocks continue to soar as the market prepares for October 17 and the deadline for legal recreational marijuana sales in Canada. This week it was announced that Coca-Cola (KO) could be ready to throw its hat into the ring with a CBD-based beverage. Integrated Cannabis Company is trading 90% higher than it was a month ago today.
1
Enjoy Coke — and the money it might make for marijuana investors
MarketWatch•5 hours ago
Enjoy Coke — and the money it might make for marijuana investors
Cannabis companies are striking deals with large beverage companies, a catalyst for marijuana stocks.
2
InvestorPlace•5 hours ago
3 Reasons Why Coca-Cola Stock Won’t Benefit from a CBD Beverage
As an integral component of Americana, Coca-Cola (NYSE:KO) doesn’t really generate much news. While Coca-Cola stock earns respect for turning around its business and making its products relevant to today’s youth, the soft-drink sector is extremely competitive. Plus, it could spark a new reason to invest in Coca-Cola stock.
3
How Coca-Cola Cannabis Drink Could Fit into Cannabis Market
Market Realist•7 hours ago
How Coca-Cola Cannabis Drink Could Fit into Cannabis Market
Earlier in this series, we discussed a recent development in which Coca-Cola (KO) was reported to be in talks with Aurora Cannabis (ACB) (ACBFF) to develop a cannabis-infused drink (MJ). The planned legalization of recreational cannabis in Canada is presenting a new market for non-cannabis players to explore. Thus, it is no surprise to see that Canopy Growth (CGC) (WEED) and HEXO (HEXO) have both pursued deals with alcoholic beverage companies.
1
Cannabis Stocks Get Another Boost from Coca-Cola Interest
Market Realist•7 hours ago
Cannabis Stocks Get Another Boost from Coca-Cola Interest
On September 17, BNN Bloomberg reported that Aurora Cannabis (ACB) (ACBFF) and Coca-Cola (KO) are in “serious talks” to develop cannabis-infused beverages. Coca-Cola joins alcoholic beverage makers Constellation Brands (STZ) and Molson Coors (TAP), which have already formed partnerships with major Canadian cannabis companies Canopy Growth (WEED) (CGC) and HEXO (HEXO), respectively.
Aurora Cannabis Inc. produces and distributes medical cannabis products in Canada and internationally. It is vertically integrated and horizontally diversified across every principal segment of the value chain, including facility engineering and design, cannabis breeding and genetics research, cannabis and hemp production, derivatives, value-add product development, home cultivation, wholesale, and retail distribution. The company's products consist of dried cannabis and cannabis oil. It has a strategic agreement with Capcium Inc.; and partnership agreement with Evio Beauty Group Ltd., as well as collaborative agreement with McGill University. Aurora Cannabis Inc. is headquartered in
EDMONTON , Sept. 18, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company"
(ACB.TO) (ACBFF) ( Frankfurt : 21P; WKN: A1C4WM) today announced it, and its wholly-owned subsidiary MedReleaf, have entered into additional supply arrangements with a number of provinces across Canada to supply a broad range of dried flower and higher margin products, such as pre-rolls, oils and capsules. In addition to supplying adult-consumer use markets in British Columbia , Alberta , Ontario , Quebec and Nova Scotia , the Company is pleased to advise of arrangements with Yukon , Manitoba , Prince Edward Island and Newfoundland and Labrador . The Aurora and MedReleaf brands are expected to have a strong presence across Canada , positioning the Company well for rapid growth in the upcoming adult use market. Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)
Aurora Cannabis Inc. (CNW Group/Aurora Cannabis Inc.)
Appointment Darren Karasiuk , EVP of Adult Usage, Global
The Company also announces the appointment of Darren Karasiuk as its new Executive Vice President of Adult Usage, Global. Mr. Karasiuk will be responsible for the execution of Aurora's commercial adult use strategy, which includes oversight of adult use retail, marketing, sales, business intelligence and analytics, partnerships and customer service.
Mr. Karasiuk joins Aurora through the acquisition of MedReleaf where he was Senior Vice-President and GM, recreational where he was responsible for MedReleaf's adult use cannabis business which included the development and introduction of the AltaVie and San Rafael '71 brands into the marketplace, as well as the stewardship of the partnership with the Woodstock Cannabis Company.
Mr. Karasiuk has deep experience in highly regulated industries, including private and public healthcare, pharma, tobacco, consumer packaged goods, and energy. Prior to joining MedReleaf, Mr. Karasiuk was Vice-President, Insights and Advisory at Deloitte where he was a leader in the firm's cannabis practice, co-authoring the firm's seminal study, "Recreational Marijuana: Insights and Opportunities." Previously, Mr. Karasiuk was Vice-President, Strategy, Corporate and Public Affairs at Environics Research, where he conducted many of Canada's earliest engagements on the cannabis sector. He has also been the Canadian associate for the Marijuana Policy Group, a leading Denver -based economic and policy consulting firm which helped shape the regulated medical and recreational cannabis markets. Mr. Karasiuk holds an MA from Western University and an MBA from Kellogg-Schulich.
Management Commentary
"We have now secured important supply arrangements from coast to coast, covering approximately 98% of the Canadian population, reflecting the scale and quality of our operations," said Terry Booth , CEO. "We will supply a large number of products to the adult use market, including dried flower, and higher margin form factors, such as capsules, oils, and pre-rolls. We are also exceptionally pleased that Darren has agreed to join our team and take on the leadership of Aurora's adult usage business. His expertise in market development within heavily regulated environments, his track record in bringing adult usage brands to market, and his connections and credibility throughout the industry are invaluable assets for us. We welcome Darren and look forward to working closely with him as Aurora rises to new heights."
Mr. Karasiuk added, "Aurora is an exceptional company, innovating and executing at the most rapid pace in the industry. The strengths of both companies – high-volume, low-cost cultivation capacity, product quality, brands and people - position us well to grow rapidly in these new and exciting markets. I look forward to being part of the team."
Granting of Stock Options and Restricted Share Units to Officers
The Company also announced today that it has granted an aggregate of 205,000 stock options and 55,000 restricted share units to officers of the Company. The stock options are exercisable at a price of $8.54 per share for a period of five years from the date of grant. Both options and RSUs vest annually over 36 months.
About Aurora
Headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 500,000 kg per year and sales and operations in 18 countries across five continents, Aurora is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.
Highly differentiated from its peers, Aurora has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale production of high quality product at ultra-low costs. Intended to be replicable and scalable globally, these production facilities are designed to produce cannabis of significant scale, with high quality, industry-leading yields, and ultra-low per gram production costs. Each of Aurora's facilities is built to meet European Union (EU) GMP standards, and its first production facility, the recently acquired MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland (formerly Pedanios), have achieved this level of certification.
In addition to the Company's rapid organic growth and strong execution on strategic M&A, which to date includes 15 companies – MedReleaf, CanvasRX, Peloton Pharmaceutical, Aurora Deutschland (formerly Pedanios), H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses, CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, Agropro, Borela, and the pending acquisition of ICC Labs – Aurora is distinguished by its reputation as a partner of choice and employer of choice in the global cannabis sector, having invested in and established strategic partnerships with a range of leading innovators, including: The Green Organic Dutchman Holdings Ltd. (TGOD.TO), Radient Technologies Inc. (RTI.V), Hempco Food and Fiber Inc. (HEMP.V), Cann Group Ltd. (CAN.AX), Micron Waste Technologies Inc. (CSE:MWM), Choom Holdings Inc. (CSE:CHOO), Namaste Technologies Inc. (TSXV:N.V), Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (CTTH), and Alcanna Inc. (CLIQ.TO).
Aurora's Common Shares trade on the TSX under the symbol "ACB", and are a constituent of the S&P/TSX Composite Index.
For more information about Aurora, please visit our investor website, investor.auroramj.com, Twitter, Facebook or Instagram
Terry Booth , CEO
Aurora Cannabis Inc.
